Dodds R A, Connor J R, Drake F, Feild J, Gowen M
SmithKline Beecham Pharmaceuticals, Department of Cellular Biochemistry, King of Prussia, Pennsylvania 19406, USA.
J Bone Miner Res. 1998 Apr;13(4):673-82. doi: 10.1359/jbmr.1998.13.4.673.
We recently identified a novel cysteine protease, cathepsin K, by random sequencing of an osteoclast cDNA library, and in situ hybridization studies in adult human tissues demonstrated high and specific expression in osteoclasts. To determine whether the expression of cathepsin K mRNA during mouse embryogenesis was more widespread, cryostat sections of early (day 11-13) and late (day 15-17) mouse fetuses were analyzed by in situ hybridization. Serial cross-sections were collected through each fetus, and co-reacted for tartrate-resistant acid phosphatase (TRAP) and nonspecific esterase (NSE), selective markers for the osteoclast, and precursor cells derived from the macrophage/monocyte lineage, respectively. In the 11-13 day fetuses, cathepsin K mRNA was not expressed in any extraskeletal tissue; at this stage of embryogenesis, no osteoclasts are present. However, in the 15-17 day fetuses, a distinctive, developmental stage-dependent pattern of cathepsin K expression was observed in osteoclasts and preosteoclasts at sites of cartilage and bone modeling. Cathepsin K positive osteoclasts differentiated within a peripheral zone of the osteogenic stacked cell layer of the cartilage rudiments (prior to ossification), migrated and/or resorbed the bone collar, and invaded the cartilage core. Furthermore, following the invasive penetration of vasculature into the degenerating cartilage core, the calcified cartilage was resorbed by cathepsin K positive mononuclear osteoclast precursors (NSE+ve, negligible TRAP); cells positive for both enzymes were identified indicative of osteoclast differentiation. The deposition of bone by osteoblasts onto the cartilage remnants is followed by mononucleated and multinucleated osteoclastic resorption; these osteoclasts demonstrated intense cathepsin K expression. Similar expression patterns were observed at sites of intramembranous ossification. No expression was observed in chondrocytes, osteoblasts, marrow, or in any other nonskeletal tissue at these time points. These data indicated that cathepsin K expression during embryogenesis occurred only following the onset of osteoclast differentiation.
我们最近通过对破骨细胞cDNA文库进行随机测序,鉴定出一种新型半胱氨酸蛋白酶——组织蛋白酶K,并且在成人组织中的原位杂交研究表明其在破骨细胞中高表达且具有特异性。为了确定组织蛋白酶K mRNA在小鼠胚胎发育过程中的表达是否更为广泛,我们通过原位杂交分析了早期(第11 - 13天)和晚期(第15 - 17天)小鼠胎儿的冷冻切片。对每个胎儿收集连续的横断面,并分别对耐酒石酸酸性磷酸酶(TRAP)和非特异性酯酶(NSE)进行共反应,它们分别是破骨细胞和源自巨噬细胞/单核细胞谱系的前体细胞的选择性标志物。在第11 - 13天的胎儿中,骨骼外任何组织均未表达组织蛋白酶K mRNA;在这个胚胎发育阶段,不存在破骨细胞。然而,在第15 - 17天的胎儿中,在软骨和骨塑形部位的破骨细胞和前破骨细胞中观察到一种独特的、依赖发育阶段的组织蛋白酶K表达模式。组织蛋白酶K阳性破骨细胞在软骨雏形(骨化之前)的成骨堆叠细胞层的外周区域分化,迁移和/或吸收骨环,并侵入软骨核心。此外,在血管侵入退化的软骨核心之后,钙化软骨被组织蛋白酶K阳性单核破骨细胞前体(NSE阳性,TRAP可忽略不计)吸收;同时表达这两种酶的细胞被鉴定为破骨细胞分化的标志。成骨细胞在软骨残余物上沉积骨后,接着是单核和多核破骨细胞的吸收;这些破骨细胞显示出强烈的组织蛋白酶K表达。在膜内成骨部位也观察到类似的表达模式。在这些时间点,软骨细胞、成骨细胞、骨髓或任何其他非骨骼组织中均未观察到表达。这些数据表明,胚胎发育过程中组织蛋白酶K的表达仅在破骨细胞分化开始后才出现。